EPISODE · Jul 17, 2026 · 57 MIN
The First Commercial Hire Makes or Breaks Your Startup with Brandon Allen
from The Crux of Medtech · host Crux of Medtech
In this episode, your host, Jordan Burgin, is joined by Brandon Allen a cardiovascular commercial leader who is CCO at Atraverse Medical, the transseptal-access company acquired by Johnson & Johnson to talk about what it really takes to commercialise cardiovascular technology.Drawing on two decades across Guidant, Boston Scientific, Biosense Webster, Acutus and Atraverse, Brandon shares the lessons that don’t make the pitch deck: surviving a cash crisis with three months of runway left, choosing between VC and family-office capital, building electrophysiology teams from scratch, and why the first commercial hire can decide whether a startup makes it.Key TopicsBrandon’s accidental path into medtech and cardiac EP from college golf to Pfizer to GuidantSurviving a cash crisis with three months of runway leftVC capital vs. family-office capital for cardiovascular startupsBuilding and developing commercial teams in electrophysiologyWhat early adoption really takes in the EP lab, the “aha moment”When to make your first commercial hire and who it should beRelated InsightsWhy family offices can beat VCs on founder control and connectionSelling the patient story, not just the clinical dataWhy engineers need to be in the room during live casesHow leaders learn more from bad leadership than goodCore ChallengesFounders confuse clinical validation with commercial adoption, underestimating how entrenched the big four (Biosense, Medtronic, Abbott, Boston) already are inside hospitals.Companies wait until approval to hire sales talent, forgetting it can take 90–180 days before a new rep delivers any revenue making the timing, and the first hire, mission-critical.🎧 Tune in now to hear how Brandon Allen turns differentiated cardiovascular technology into real commercial traction, from cash crises to clean exits.
What this episode covers
In this episode, your host, Jordan Burgin, is joined by Brandon Allen a cardiovascular commercial leader who is CCO at Atraverse Medical, the transseptal-access company acquired by Johnson & Johnson to talk about what it really takes to commercialise cardiovascular technology.Drawing on two decades across Guidant, Boston Scientific, Biosense Webster, Acutus and Atraverse, Brandon shares the lessons that don’t make the pitch deck: surviving a cash crisis with three months of runway left, choosing between VC and family-office capital, building electrophysiology teams from scratch, and why the first commercial hire can decide whether a startup makes it.Key TopicsBrandon’s accidental path into medtech and cardiac EP from college golf to Pfizer to GuidantSurviving a cash crisis with three months of runway leftVC capital vs. family-office capital for cardiovascular startupsBuilding and developing commercial teams in electrophysiologyWhat early adoption really takes in the EP lab, the “aha moment”When to make your first commercial hire and who it should beRelated InsightsWhy family offices can beat VCs on founder control and connectionSelling the patient story, not just the clinical dataWhy engineers need to be in the room during live casesHow leaders learn more from bad leadership than goodCore ChallengesFounders confuse clinical validation with commercial adoption, underestimating how entrenched the big four (Biosense, Medtronic, Abbott, Boston) already are inside hospitals.Companies wait until approval to hire sales talent, forgetting it can take 90–180 days before a new rep delivers any revenue making the timing, and the first hire, mission-critical.🎧 Tune in now to hear how Brandon Allen turns differentiated cardiovascular technology into real commercial traction, from cash crises to clean exits.
NOW PLAYING
The First Commercial Hire Makes or Breaks Your Startup with Brandon Allen
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m